FDA Reclassification of Hydrocodone to Schedule II Could Boost Sales.
PALO ALTO, CA, Dec. 5, 2013 - The PAWS Pet Company, Inc. (OTCQB:PAWS), is pleased to announce that work on the name change to Praxsyn Corporation is nearing completion and that the Company expects to be able to file a request with FINRA early next week along with filing the necessary filings and disclosures with the SEC and the State of Illinois.
Palo Alto, CA – October 17, 2013 - The PAWS Pet Company, Inc. (OTCQB:PAWS), is pleased to announce that the three short-term convertible notes that were negotiated with Asher Enterprises, Inc. in 2012 have been paid in full. The final interest payment on the last of those notes was paid today.
The PAWS Pet Company, Inc. (OTCQB:PAWS), today announced that as part of its ongoing transition from the pet space to the pharmaceutical space the Company has begun the process of changing its name to Praxsyn Corporation and will also change its state of incorporation from from Illinois to Nevada.
Palo Alto, CA – Sept 10, 2013 - The PAWS Pet Company, Inc. (OTCQB:PAWS) (OTCPK:PAWS), announced it has signed a letter of intent to acquire Pharmacy Development, Inc. dba MESA Pharmacy, of Irvine, California as part on its new strategy to be a dominant player in the delivery of pharmaceutical products to consumers.